Your browser doesn't support javascript.
loading
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.
Budde, Lihua E; Wu, David; Martin, Daniel B; Philip, Mary; Shustov, Andrei R; Smith, Stephen D; Gooley, Ted A; Chen, Tara L; Libby, Edward N; Chen, Eric Y; Kojouri, Kiarash; Langerak, Alan; Roden, Jennifer E; Press, Oliver W; Gopal, Ajay K.
Afiliación
  • Budde LE; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
  • Wu D; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
  • Martin DB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Philip M; Department of Medicine, Divisions of Medical Oncology and Hematology, University of Washington, Seattle, WA, USA.
  • Shustov AR; Department of Medicine, Divisions of Medical Oncology and Hematology, University of Washington, Seattle, WA, USA.
  • Smith SD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Chen TL; Department of Medicine, Divisions of Medical Oncology and Hematology, University of Washington, Seattle, WA, USA.
  • Libby EN; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Chen EY; Group Health Permanente, Seattle, WA, USA.
  • Kojouri K; Skagit Valley Hospital Regional Center, Mount Vernon, WA, USA.
  • Langerak A; St. Alphonsus Regional Medical Center, Boise, ID, USA.
  • Roden JE; Department of Medicine, Divisions of Medical Oncology and Hematology, University of Washington, Seattle, WA, USA.
  • Press OW; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Br J Haematol ; 183(4): 601-607, 2018 11.
Article en En | MEDLINE | ID: mdl-30596402
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos